Iron homeostasis and trypanosoma brucei associated immunopathogenicity development: A battle/quest for iron

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Stijlemans, Benoit ^a,b   Beschin, Alain ^a,b   Magez, Stefan ^a,b   Van Ginderachter, Jo A ^a,b   De Baetselier, Patrick ^a,b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

AFRICAN TRYPANOSOMIASIS; ANEMIA; BLOODSTREAM INFECTION; HOMEOSTASIS; HOST; HOST PARASITE INTERACTION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IRON HOMEOSTASIS; IRON TRANSPORT; KINETOPLASTID LIFE CYCLE STAGE; NONHUMAN; REVIEW; STEADY STATE; TRYPANOSOMA BRUCEI; ANIMAL; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; TRYPANOSOMA BRUCEI BRUCEI;

MAMMALIA; TRYPANOSOMA BRUCEI;

ANEMIA; ANIMALS; HOMEOSTASIS; HUMANS; IRON; MACROPHAGE ACTIVATION; MACROPHAGES; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 84930655083     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/819389     Document Type: Review

References (166)

1. M. Nairz, D. Haschka, E. Demetz, and G. Weiss, "Iron at the interface of immunity and infection," Frontiers in Pharmacology, vol. 5, article 152, 2014.
2. R. Sutak, E. Lesuisse, J. Tachezy, and D. R. Richardson, "Crusade for iron: iron uptake in unicellular eukaryotes and its signif-cance for virulence," Trends in Microbiology, vol. 16, no. 6, pp. 261-268, 2008.
3. M.W. Hentze, M.U. Muckenthaler, B. Galy, and C. Camaschella, "Two to tango: regulation of Mammalian iron metabolism," Cell, vol. 142, no. 1, pp. 24-38, 2010.
4. S. Silva-Gomes, S. Vale-Costa, R. Appelberg, and M. S. Gomes, "Iron in intracellular infection: to provide or to deprive?" Frontiers in Cellular and Infection Microbiology, vol. 3, article 96, 2013.
5. K. P. Haley and E. P. Skaar, "A battle for iron: host sequestration and Staphylococcus aureus acquisition," Microbes and Infection, vol. 14, no. 3, pp. 217-227, 2012.
6. M. Nairz, A. Schroll, T. Sonnweber, and G. Weiss, "The struggle for iron-a metal at the host-pathogen interface," Cellular Microbiology, vol. 12, no. 12, pp. 1691-1702, 2010.
7. A. del Castillo-Rueda and P. Khosravi-Shahi, "The role of iron in the interaction between host and pathogen," Medicina Clinica, vol. 134, no. 10, pp. 452-456, 2010.
8. M. I. Hood and E. P. Skaar, "Nutritional immunity: transition metals at the pathogen-host interface," Nature Reviews Microbiology, vol. 10, no. 8, pp. 525-537, 2012.
9. J. E. Cassat and E. P. Skaar, "Iron in infection and immunity," Cell Host & Microbe, vol. 13, no. 5, pp. 509-519, 2013.
10. M. P. Barrett, R. J. S. Burchmore, A. Stich et al., "The trypanoso-miases," The Lancet, vol. 362, no. 9394, pp. 1469-1480, 2003.
11. J. R. Franco, P. P. Simarro, A. Diarra, and J. G. Jannin, "Epidemiology of human African trypanosomiasis," Clinical Epidemiology, vol. 6, pp. 257-275, 2014.
12. A. P. M. Shaw, G. Cecchi, G. R. W. Wint, R. C. Mattioli, and T. P. Robinson, "Mapping the economic benefts to livestock keepers from intervening against bovine trypanosomosis in Eastern Africa," Preventive Veterinary Medicine, vol. 113, no. 2, pp. 197-210, 2014.
13. A. Beschin, J. Van Den Abbeele, P. De Baetselier, and E. Pays, "African trypanosome control in the insect vector and mammalian host," Trends in Parasitology, vol. 30, no. 11, pp. 538-547, 2014.
14. M. T. Silva and M. Correia-Neves, "Neutrophils and macrophages: the main partners of phagocyte cell systems," Frontiers in Immunology, vol. 3, article 174, 2012.
15. B. Stijlemans, M. Guilliams, G. Raes, A. Beschin, S. Magez, and P. De Baetselier, "African trypanosomosis: from immune escape and immunopathology to immune intervention," Veterinary Parasitology, vol. 148, no. 1, pp. 3-13, 2007.
16. J. van den Abbeele, Y. Claes, D. van Bockstaele, D. le Ray, and M. Coosemans, "Try panosomabucei spp. development in the tsetse fy: characterization of the post-mesocyclic stages in the foregut and proboscis," Parasitology, vol. 118, part 5, pp. 469-478, 1999.
17. M. Oberle, O. Balmer, R. Brun, and I. Roditi, "Bottlenecks and the maintenance of minor genotypes during the life cycle of Try panosomabrucei," PLoS Pathogens, vol. 6, no. 7, Article ID e1001023, 2010.
18. B. M. Mony and K. R. Matthews, "Assembling the components of the quorum sensing pathway in African trypanosomes," Molecular Microbiology, 2015.
19. B. M. Mony, P. MacGregor, A. Ivens et al., "Genome-wide dissection of the quorum sensing signalling pathway in Try panosomabrucei," Nature, vol. 505, no. 7485, pp. 681-685, 2014.
20. B. Stijlemans, A. Vankrunkelsven, G. Caljon et al., "The central role of macrophages in trypanosomiasis-associated anemia: rationale for therapeutical approaches," Endocrine, Metabolic & Immune Disorders-Drug Targets, vol. 10, no. 1, pp. 71-82, 2010.
21. D. Malvy and F. Chappuis, "Sleeping sickness," Clinical Microbiology and Infection, vol. 17, no. 7, pp. 986-995, 2011.
22. World Health Organization, "Control and surveillance of human African trypanosomiasis," World Health Organization Technical Report Series 984, World Health Organization, 2013.
23. G. Rocha, A. Martins, G. Gama, F. Brandao, and J. Atouguia, "Possible cases of sexual and congenital transmission of sleeping sickness," The Lancet, vol. 363, no. 9404, p. 247, 2004.
24. K. Picozzi, M. Carrington, and S. C. Welburn, "A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense," Experimental Parasitology, vol. 118, no. 1, pp. 41-46, 2008.
25. P. Uzureau, S. Uzureau, L. Lecordier et al., "Mechanism of Try panosomabrucei gambiense resistance to human serum," Nature, vol. 501, no. 7467, pp. 430-434, 2013.
26. S. L. Wastling and S. C. Welburn, "Diagnosis of human sleeping sickness: sense and sensitivity," Trends in Parasitology, vol. 27, no. 9, pp. 394-402, 2011.
27. E. M. Fèvre, B. V. Wissmann, S. C. Welburn, and P. Lutumba, "The burden of human African trypanosomiasis," PLoS Neglected Tropical Diseases, vol. 2, no. 12, article e333, 2008.
28. A. A. Ilemobade, "Tsetse and trypanosomosis in Africa: the challenges, the opportunities," Onderstepoort Journal of Veterinary Research, vol. 76, no. 1, pp. 35-40, 2009.
29. F. L. Greca and S. Magez, "Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?" Human Vaccines, vol. 7, no. 11, pp. 1225-1233, 2011.
30. M. P. Barrett, I. M. Vincent, R. J. Burchmore, A. J. Kazibwe, and E. Matovu, "Drug resistance in human African trypanosomia-sis," Future Microbiology, vol. 6, no. 9, pp. 1037-1047, 2011.
31. R. T. Jacobs, B. Nare, and M. A. Phillips, "State of the art in African trypanosome drug discovery," Current Topics in Medicinal Chemistry, vol. 11, no. 10, pp. 1255-1274, 2011.
32. C. Naula and R. Burchmore, "A plethora of targets, a paucity of drugs: progress towards the development of novel chemotherapies for human African trypanosomiasis," Expert Review of Anti-Infective Terapy, vol. 1, no. 1, pp. 157-165, 2003.
33. J. C. Rodrigues, J. L. Godinho, and W. de Souza, "Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure," in Proteins and Proteomics of Leishmania and Trypanosoma, vol. 74 of Subcellular Biochemistry, pp. 1-42, Springer, Amsterdam, The Netherlands, 2014.
34. J. R. Seed and M. A. Wenck, "Role of the long slender to short stumpy transition in the life cycle of the African trypanosomes," Kinetoplastid Biology and Disease, vol. 2, article 3, 2003.
35. S. K. A. Natesan, L. Peacock, K. Matthews, W. Gibson, and M. C. Field, "Activation of endocytosis as an adaptation to the mammalian host by trypanosomes," Eukaryotic Cell, vol. 6, no. 11, pp. 2029-2037, 2007.
36. A. E. Gruszynski, F. J. van Deursen, M. C. Albareda et al., "Regulation of surface coat exchange by diferentiating African trypanosomes," Molecular and Biochemical Parasitology, vol. 147, no. 2, pp. 211-223, 2006.
37. K. R. Matthews, J. R. Ellis, and A. Paterou, "Molecular regulation of the life cycle of African trypanosomes," Trends in Parasitology, vol. 20, no. 1, pp. 40-47, 2004.
38. N. G. Jones, E. B. Tomas, E. Brown, N. J. Dickens, T. C. Hammarton, and J. C. Mottram, "Regulators of Trypanosoma brucei cell cycle progression and diferentiation identifed using a kinome-wide RNAi screen," PLoS Pathogens, vol. 10, no. 1, Article ID e1003886, 2014.
39. M. C. Taylor and J. M. Kelly, "Iron metabolism in trypanoso-matids, and its crucial role in infection," Parasitology, vol. 137, no. 6, pp. 899-917, 2010.
40. D. Steverding, "Bloodstream forms of Try panosomabrucei require only small amounts of iron for growth," Parasitology Research, vol. 84, no. 1, pp. 59-62, 1997.
41. F. Bringaud, L. Rivìere, and V. Coustou, "Energy metabolism of trypanosomatids: adaptation to available carbon sources," Molecular and Biochemical Parasitology, vol. 149, no. 1, pp. 1-9, 2006.
42. J. Saas, K. Ziegelbauer, A. von Haeseler, B. Fast, and M. Boshart, "A developmentally regulated aconitase related to iron-regulatory protein-1 is localized in the cytoplasm and in the mitochondrion of Try panosomabrucei," The Journal of Biological Chemistry, vol. 275, no. 4, pp. 2745-2755, 2000.
43. M. Chaudhuri, R. D. Ott, and G. C. Hill, "Trypanosome alternative oxidase: from molecule to function," Trends in Parasitology, vol. 22, no. 10, pp. 484-491, 2006.
44. A. Hofer, P. P. Schmidt, A. Gräslund, and L. Telander, "Cloning and characterization of the R1 and R2 subunits of ribonu-cleotide reductase from Trypanosoma brucei," Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 13, pp. 6959-6964, 1997.
45. S. R. Wilkinson, S. R. Prathalingam, M. C. Taylor, A. Ahmed, D. Horn, and J. M. Kelly, "Functional characterisation of the iron superoxide dismutase gene repertoire in Try panosomabrucei," Free Radical Biology and Medicine, vol. 40, no. 2, pp. 198-209, 2006.
46. M. Kabiri and D. Steverding, "Identifcation of a develop-mentally regulated iron superoxide dismutase of Try panosomabrucei," Biochemical Journal, vol. 360, no. 1, pp. 173-177, 2001.
47. D. Steverding, D. W. Sexton, N. Chrysochoidi, and F. Cao, "Trypanosoma brucei transferrin receptor can bind C-lobe and N-lobe fragments of transferrin," Molecular and Biochemical Parasitology, vol. 185, no. 2, pp. 99-105, 2012.
48. D. Steverding, "The transferrin receptor of Try panosomabrucei," Parasitology International, vol. 48, no. 3, pp. 191-198, 2000.
49. P. Borst, "Transferrin receptor, antigenic variation and the prospect of a trypanosome vaccine," Trends in Genetics, vol. 7, no. 10, pp. 307-309, 1991.
50. D. Steverding, "The signifcance of transferrin receptor variation in Trypanosoma brucei," Trends in Parasitology, vol. 19, no. 3, pp. 125-127, 2003.
51. A. Mehlert and M. A. J. Ferguson, "Structure of the gly-cosylphosphatidylinositol anchor of the Try panosomabrucei transferrin receptor," Molecular and Biochemical Parasitology, vol. 151, no. 2, pp. 220-223, 2007.
52. A. Mehlert, M. R. Wormald, and M. A. J. Ferguson, "Modeling of the N-glycosylated transferrin receptor suggests how trans-ferrin binding can occur within the surface coat of trypanosoma brucei," PLoS Pathogens, vol. 8, no. 4, Article ID e1002618, 2012.
53. D. Steverding, Y.-D. Stierhof, H. Fuchs, R. Tauber, and P. Overath, "Transferrin-binding protein complex is the receptor for transferrin uptake in Try panosomabrucei," The Journal of Cell Biology, vol. 131, no. 5, pp. 1173-1182, 1995.
54. R. Mussmann, M. Engstler, H. Gerrits et al., "Factors afecting the level and localization of the transferrin receptor in Try-panosoma brucei," The Journal of Biological Chemistry, vol. 279, no. 39, pp. 40690-40698, 2004.
55. H. G. A. M. van Luenen, R. Kief, R. Mussmann, M. Engstler, B. ter Riet, and P. Borst, "Trypanosomes change their transferrin receptor expression to allow efective uptake of host transferrin," Molecular Microbiology, vol. 58, no. 1, pp. 151-165, 2005.
56. W. Bitter, H. Gerrits, R. Kief, and P. Borst, "The role of transferrin-receptor variation in the host range of Try panosomabrucei," Nature, vol. 391, no. 6666, pp. 499-502, 1998.
57. H. Gerrits, R. Mußmann, W. Bitter, R. Kief, and P. Borst, "The physiological signifcance of transferrin receptor variations in Try panosomabrucei," Molecular and Biochemical Parasitology, vol. 119, no. 2, pp. 237-247, 2002.
58. D. Salmon, F. Paturiaux-Hanocq, P. Poelvoorde, L. Vanhamme, and E. Pays, "Try panosomabrucei: growth diferences in different mammalian sera are not due to the species-specifcity of transferrin," Experimental Parasitology, vol. 109, no. 3, pp. 188-194, 2005.
59. C. Cordon-Obras, J. Cano, D. González-Pacanowska, A. Benito, M. Navarro, and J.-M. Bart, "Try panosomabrucei gambiense adaptation to diferent Mammalian Sera is associated with VSG expression site plasticity," PLoS ONE, vol. 8, no. 12, Article ID e85072, 2013.
60. B. Fast, K. Kremp, M. Boshart, and D. Steverding, "Iron-dependent regulation of transferrin receptor expression in Try panosomabrucei," Biochemical Journal, vol. 342, part 3, pp. 691-696, 1999.
61. R. Mußmann, H. Janssen, J. Calafat et al., "The expression level determines the surface distribution of the transferrin receptor in Try panosomabrucei," Molecular Microbiology, vol. 47, no. 1, pp. 23-35, 2003.
62. D. Salmon, J. Hanocq-Quertier, F. Paturiaux-Hanocq et al., "Characterization of the ligand-binding site of the transferrin receptor in Tr y pan os oma br u ce i demonstrates a structural relationship with the N-terminal domain of the variant surface glycoprotein," The EMBO Journal, vol. 16, no. 24, pp. 7272-7278, 1997.
63. A. Pal, B. S. Hall, T. R. Jefries, and M. C. Field, "Rab5 and Rab11 mediate transferrin and anti-variant surface glycoprotein antibody recycling in Try panosomabrucei," Biochemical Journal, vol. 374, no. 2, pp. 443-451, 2003.
64. B. Hall, C. L. Allen, D. Goulding, and M. C. Field, "Both of the Rab5 subfamily small GTPases of Trypanosoma brucei are essential and required for endocytosis," Molecular and Biochemical Parasitology, vol. 138, no. 1, pp. 67-77, 2004.
65. C. L. Allen, D. Goulding, and M. C. Field, "Clathrin-mediated endocytosis is essential in Try panosomabrucei," The EMBO Journal, vol. 22, no. 19, pp. 4991-5002, 2003.
66. B. S. Hall, C. Gabernet-Castello, A. Voak et al., "TbVps34, the trypanosome orthologue of Vps34, is required for Golgi complex segregation," The Journal of Biological Chemistry, vol. 281, pp. 27600-27612, 2006.
67. S. Subramanya and K. Mensa-Wilmot, "Diacylglycerol-stimulated endocytosis of transferrin in trypanosomatids is dependent on tyrosine kinase activity," PLoS ONE, vol. 5, no. 1, Article ID e8538, 2010.
68. A. Maier and D. Steverding, "Low afnity of Try panosoma brucei transferrin receptor to apotransferrin at pH 5 explains the fate of the ligand during endocytosis," FEBS Letters, vol. 396, no. 1, pp. 87-89, 1996.
69. D. Steverding, "On the signifcance of host antibody response to the Try panosomabrucei transferrin receptor during chronic infection," Microbes and Infection, vol. 8, no. 12-13, pp. 2777-2782, 2006.
70. T. C. O'Brien, Z. B. Mackey, R. D. Fetter et al., "A parasite cysteine protease is key to host protein degradation and iron acquisition," The Journal of Biological Chemistry, vol. 283, no. 43, pp. 28934-28943, 2008.
71. B. S. Hall, E. Smith, W. Langer, L. A. Jacobs, D. Goulding, and M. C. Field, "Developmental variation in Rab11-dependent trafcking in Try panosomabrucei," Eukaryotic Cell, vol. 4, no. 5, pp. 971-980, 2005.
72. T. R. Jefries, G. W. Morgan, and M. C. Field, "A developmentally regulated rab11 homologue in Try panosomabrucei is involved in recycling processes," Journal of Cell Science, vol. 114, no. 14, pp. 2617-2626, 2001.
73. M. C. Taylor, A. P. Mclatchie, and J. M. Kelly, "Evidence that transport of iron from the lysosome to the cytosol in African trypanosomes is mediated by a mucolipin orthologue," Molecular Microbiology, vol. 89, no. 3, pp. 420-432, 2013.
74. T. Tanaka, Y. Abe, N. Inoue et al., "The detection of bovine lactoferrin binding protein on Try panosomabrucei," Journal of Veterinary Medical Science, vol. 66, no. 6, pp. 619-625, 2004.
75. V. M. Boradia, M. Raje, and C. I. Raje, "Protein moonlighting in iron metabolism: glyceraldehyde-3-phosphate dehydrogenase (GAPDH)," Biochemical Society Transactions, vol. 42, no. 6, pp. 1796-1801, 2014.
76. K. Furuyama, K. Kaneko, and P. D. Vargas, "Heme as a mag-nifcient molecule with multiple missions: heme determines its own fate and governs cellular homeostasis," Tohoku Journal of Experimental Medicine, vol. 213, no. 1, pp. 1-16, 2007.
77. K. E. J. Tripodi, S. M. M. Bravo, and J. A. Cricco, "Role of heme and heme-proteins in trypanosomatid essential metabolic pathways," Enzyme Research, vol. 2011, Article ID 873230, 12 pages, 2011.
78. L. Kǒrený, J. Lukěs, and M. Oborník, "Evolution of the haem synthetic pathway in kinetoplastid fagellates: an essential pathway that is not essential afer all?" International Journal for Parasitology, vol. 40, no. 2, pp. 149-156, 2010.
79. B. Vanhollebeke, G. de Muylder, M. J. Nielsen et al., "A haptoglobin-hemoglobin receptor conveys innate immunity to Try panosomabrucei in humans," Science, vol. 320, no. 5876, pp. 677-681, 2008.
80. M. K. Higgins, O. Tkachenko, A. Brown, J. Reed, J. Raper, and M. Carrington, "Structure of the trypanosome haptoglobin-hemoglobin receptor and implications for nutrient uptake and innate immunity," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 5, pp. 1905-1910, 2013.
81. H. van Xong, L. Vanhamme, M. Chamekh et al., "A VSG expression site-associated gene confers resistance to human serum in Try panosomarhodesiense," Cell, vol. 95, no. 6, pp. 839-846, 1998.
82. P. Capewell, C. Clucas, E. DeJesus et al., "The TgsGP gene is essential for resistance to human serum in Try panosomabrucei gambiense," PLoS Pathogens, vol. 9, no. 10, Article ID e1003686, 2013.
83. J. Mach, J. Tachezy, and R. Sutak, "Efcient iron uptake via a reductive mechanism in procyclic Try panosomabrucei," Journal of Parasitology, vol. 99, no. 2, pp. 363-364, 2013.
84. G. W. Morgan, C. L. Allen, T. R. Jefries, M. Hollinshead, and M. C. Field, "Developmental and morphological regulation of clathrin-mediated endocytosis in Try panosomabrucei," Journal of Cell Science, vol. 114, no. 14, pp. 2605-2615, 2001.
85. K. Kita, C. Nihei, and E. Tomitsuka, "Parasite mitochondria as drug target: diversity and dynamic changes during the life cycle," Current Medicinal Chemistry, vol. 10, no. 23, pp. 2535-2548, 2003.
86. M. Chaudhuri, W. Ajayi, and G. C. Hill, "Biochemical and molecular properties of the Try panosomabrucei alternative oxidase," Molecular and Biochemical Parasitology, vol. 95, no. 1, pp. 53-68, 1998.
87. M. S. Leite, R. Tomaz, J. H. M. Oliveira, P. L. Oliveira, and J. R. Meyer-Fernandes, "Trypanosoma brucei brucei: efects of ferrous iron and heme on ecto-nucleoside triphosphate diphosphohydrolase activity," Experimental Parasitology, vol. 121, no. 2, pp. 137-143, 2009.
88. S. Lu, T. Suzuki, N. Iizuka et al., "Try panosoma brucei vacuolar protein sorting 41 (VPS41) is required for intracellular iron utilization and maintenance of normal cellular morphology," Parasitology, vol. 134, no. 11, pp. 1639-1647, 2007.
89. O. Smíd, E. Horákova, V. Vilímova et al., "Knock-downs of iron-sulfur cluster assembly proteins IscS and IscU down-regulate the active mitochondrion of procyclic Try panosomabrucei," The Journal of Biological Chemistry, vol. 281, no. 39, pp. 28679-28686, 2006.
90. G. Weiss and L. T. Goodnough, "Anemia of chronic disease," The New England Journal of Medicine, vol. 352, no. 10, pp. 1011-1023, 2005.
91. M. C. Linder, "Mobilization of stored iron in mammals: a review," Nutrients, vol. 5, no. 10, pp. 4022-4050, 2013.
92. A. T. McKie, D. Barrow, G. O. Latunde-Dada et al., "An iron-regulated ferric reductase associated with the absorption of dietary iron," Science, vol. 291, no. 5509, pp. 1755-1759, 2001.
93. A. T. McKie, "The role of Dcytb in iron metabolism: an update," Biochemical Society Transactions, vol. 36, no. 6, pp. 1239-1241, 2008.
94. K. E. Finberg, "Regulation of systemic iron homeostasis," Current Opinion in Hematology, vol. 20, no. 3, pp. 208-214, 2013.
95. T. Ganz, "Macrophages and systemic iron homeostasis," Journal of Innate Immunity, vol. 4, no. 5-6, pp. 446-453, 2012.
96. S. Immenschuh, E. Baumgart-Vogt, and S. Mueller, "Heme oxygenase-1 and iron in liver infammation: a complex alliance," Current Drug Targets, vol. 11, no. 12, pp. 1541-1550, 2010.
97. C. Beaumont and F. Canonne-Hergaux, "Erythrophagocyto-sis and recycling of heme iron in normal and pathological conditions; regulation by hepcidin," Trans fusion Clinique et Biologique, vol. 12, no. 2, pp. 123-130, 2005.
98. K. Pantopoulos, S. K. Porwal, A. Tartakof, and L. Devireddy, "Mechanisms of mammalian iron homeostasis," Biochemistry, vol. 51, no. 29, pp. 5705-5724, 2012.
99. D. Meynard, J. L. Babitt, and H. Y. Lin, "The liver: conductor of systemic iron balance," Blood, vol. 123, no. 2, pp. 168-176, 2014.
100. W. N. Kong, Y. H. Lei, and Y. Z. Chang, "The regulation of iron metabolism in the mononuclear phagocyte system," Expert Review of Hematology, vol. 6, no. 4, pp. 411-418, 2013.
101. G. Musci, F. Polticelli, and B. M. C. Patti, "Ceruloplasmin-ferroportin system of iron trafc in vertebrates," World Journal of Biological Chemistry, vol. 5, no. 2, pp. 204-215, 2014.
102. A. D. Varsat, A. Ciechanover, and H. F. Lodish, "pH and the recycling of transferrin during receptor-mediated endocytosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 8 I, pp. 2258-2262, 1983.
103. Z. M. Qian, H. Li, H. Sun, and K. Ho, "Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway," Pharmacological Reviews, vol. 54, no. 4, pp. 561-587, 2002.
104. A. N. Luck and A. B. Mason, "Transferrin-mediated cellular iron delivery," Current Topics in Membranes, vol. 69, pp. 3-35, 2012.
105. D. Zhang, E. Meyron-Holtz, and T. A. Rouault, "Renal iron metabolism: transferrin iron delivery and the role of iron regulatory proteins," Journal of the American Society of Nephrology, vol. 18, no. 2, pp. 401-406, 2007.
106. N. Sheokand, H. Malhotra, S. Kumar et al., "Moonlighting cell-surface GAPDH recruits apotransferrin to efect iron egress from mammalian cells," Journal of Cell Science, vol. 127, no. 19, pp. 4279-4291, 2014.
107. C. I. Raje, S. Kumar, A. Harle, J. S. Nanda, and M. Raje, "The macrophage cell surface glyceraldehyde-3-phosphate dehydro-genase is a novel transferrin receptor," The Journal of Biological Chemistry, vol. 282, no. 5, pp. 3252-3261, 2007.
108. T. Ganz and E. Nemeth, "Hepcidin and disorders of iron metabolism," Annual Review of Medicine, vol. 62, pp. 347-360, 2011.
109. T. Ganz, "Hepcidin and iron regulation, 10 years later," Blood, vol. 117, no. 17, pp. 4425-4433, 2011.
110. C. Peyssonnaux, A. S. Zinkernagel, R. A. Schuepbach et al., "Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)," The Journal of Clinical Investigation, vol. 117, no. 7, pp. 1926-1932, 2007.
111. M. Mastrogiannaki, P. Matak, J. R. R. Mathieu et al., "Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in ery-thropoiesis," Haematologica, vol. 97, no. 6, pp. 827-834, 2012.
112. J. B. Goodnough, E. Ramos, E. Nemeth, and T. Ganz, "Inhibition of hepcidin transcription by growth factors," Hepatology, vol. 56, no. 1, pp. 291-299, 2012.
113. A. E. Armitage, L. A. Eddowes, U. Gileadi et al., "Hepcidin regulation by innate immune and infectious stimuli," Blood, vol. 118, no. 15, pp. 4129-4139, 2011.
114. Y. Hou, S. Zhang, L. Wang et al., "Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element," Gene, vol. 511, no. 2, pp. 398-403, 2012.
115. C. Peyssonnaux, A. S. Zinkernagel, V. Datta, X. Lauth, R. S. Johnson, and V. Nizet, "TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens," Blood, vol. 107, no. 9, pp. 3727-3732, 2006.
116. M. Teurl, I. Teurl, K. Hochegger et al., "Kupfer cells modulate iron homeostasis in mice via regulation of hepcidin expression," Journal of Molecular Medicine, vol. 86, no. 7, pp. 825-835, 2008.
117. E. Nemeth, M. S. Tuttle, J. Powelson et al., "Hepcidin regulates cellular iron efux by binding to ferroportin and inducing its internalization," Science, vol. 306, no. 5704, pp. 2090-2093, 2004.
118. M. Nairz, A. Schroll, E. Demetz, I. Tancevski, I. Teurl, and G. Weiss, "'Ride on the ferrous wheel'-the cycle of iron in macrophages in health and disease," Immunobiology, vol. 220, no. 2, pp. 280-294, 2015.
119. J. Naessens, "Bovine trypanotolerance: a natural ability to prevent severe anaemia and haemophagocytic syndrome?" International Journal for Parasitology, vol. 36, no. 5, pp. 521-528, 2006.
120. V. O. Taiwo and V. O. Anosa, "In vitro erythrophagocytosis by cultured macrophages stimulated with extraneous substances and those isolated from the blood, spleen and bone marrow of Boran and N'Dama cattle infected with Try panosoma congolense and Try panosomavivax," Onderstepoort Journal of Veterinary Research, vol. 67, no. 4, pp. 273-287, 2000.
121. D. Berthier, I. Chantal, S. Tevenon et al., "Study of bovine trypanotolerance by whole transcriptome analysis: toward identifcation of the involved genes," Annals of the New York Academy of Sciences, vol. 1149, pp. 71-76, 2008.
122. S. Magez and G. Caljon, "Mouse models for pathogenic African trypanosomes: unravelling the immunology of host-parasite-vector interactions," Parasite Immunology, vol. 33, no. 8, pp. 423-429, 2011.
123. S. Magez, A. Schwegmann, R. Atkinson et al., "The role of B-cells and IgM antibodies in parasitemia, anemia, and VSG switching in Try panosomabrucei-infected mice," PLoS Pathogens, vol. 4, no. 8, Article ID e1000122, 2008.
124. J. Naessens, S. G. A. Leak, D. J. Kennedy, S. J. Kemp, and A. J. Teale, "Responses of bovine chimaeras combining try-panosomosis resistant and susceptible genotypes to experimental infection with Trypanosoma congolense," Veterinary Parasitology, vol. 111, no. 2-3, pp. 125-142, 2003.
125. B. Stijlemans, A. Vankrunkelsven, L. Brys, S. Magez, and P. de Baetselier, "Role of iron homeostasis in trypanosomiasis-associated anemia," Immunobiology, vol. 213, no. 9-10, pp. 823-835, 2008.
126. K. Nishimura, H. Nakaya, H. Nakagawa, S. Matsuo, Y. Ohnishi, and S. Yamasaki, "Efect of Tr ypanosoma brucei brucei on erythropoiesis in infected rats," Journal of Parasitology, vol. 97, no. 1, pp. 88-93, 2011.
127. B. Stijlemans, A. Vankrunkelsven, L. Brys, G. Raes, S. Magez, and P. de Baetselier, "Scrutinizing the mechanisms underlying the induction of anemia of infammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis," Microbes and Infection, vol. 12, no. 5, pp. 389-399, 2010.
128. H. A. Noyes, M. H. Alimohammadian, M. Agaba et al., "Mechanisms controlling anaemia in Trypanosoma congolense infected mice," PLoS ONE, vol. 4, no. 4, Article ID e5170, 2009.
129. M. Wlaschek and K. Scharfetter-Kochanek, "Oxidative stress in chronic venous leg ulcers," Wound Repair and Regeneration, vol. 13, no. 5, pp. 452-461, 2005.
130. K. M. Musallam, M. D. Cappellini, J. C. Wood et al., "Elevated liver iron concentration is a marker of increased morbidity in patients with α thalassemia intermedia," Haematologica, vol. 96, no. 11, pp. 1605-1612, 2011.
131. S. Xiong, H. She, and H. Tsukamoto, "Signaling role of iron in NF-kappa B activation in hepatic macrophages," Comparative Hepatology, vol. 3, supplement 1, p. S36, 2004.
132. T. Bosschaerts, Y. Morias, B. Stijlemans et al., "IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-αB p50 member in Try panosoma congolense infection-resistant C57BL/6 mice," European Journal of Immunology, vol. 41, no. 11, pp. 3270-3280, 2011.
133. T. Bosschaerts, M. Guilliams, W. Noel et al., "Alternatively activated myeloid cells limit pathogenicity associated with african trypanosomiasis through the IL-10 inducible gene selenoprotein P," The Journal of Immunology, vol. 180, no. 9, pp. 6168-6175, 2008.
134. A. Sindrilaru, T. Peters, S. Wieschalka et al., "An unrestrained proinfammatory M1 macrophage population induced by iron impairs wound healing in humans and mice," Journal of Clinical Investigation, vol. 121, no. 3, pp. 985-997, 2011.
135. S. Magez, M. Radwanska, A. Beschin, K. Sekikawa, and P. de Baetselier, "Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections," Infection and Immunity, vol. 67, no. 6, pp. 3128-3132, 1999.
136. S. Magez, C. Truyens, M. Merimi et al., "P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis," Journal of Infectious Diseases, vol. 189, no. 3, pp. 527-539, 2004.
137. M. B. Drennan, B. Stijlemans, J. van den Abbeele et al., "The induction of a type 1 immune response following a Trypanosomabrucei infection is MyD88 dependent," Journal of Immunology, vol. 175, no. 4, pp. 2501-2509, 2005.
138. T. Bosschaerts, M. Guilliams, B. Stijlemans et al., "Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-α and MyD88 signaling," PLoS Pathogens, vol. 6, no. 8, Article ID e1001045, pp. 35-36, 2010.
139. A. Sica, P. Invernizzi, and A. Mantovani, "Macrophage plasticity and polarization in liver homeostasis and pathology," Hepatol-ogy, vol. 59, no. 5, pp. 2034-2042, 2014.
140. G. Cairo, S. Recalcati, A. Mantovani, and M. Locati, "Iron trafcking and metabolism in macrophages: contribution to the polarized phenotype," Trends in Immunology, vol. 32, no. 6, pp. 241-247, 2011.
141. S. Recalcati, M. Locati, E. Gammella, P. Invernizzi, and G. Cairo, "Iron levels in polarized macrophages: regulation of immunity and autoimmunity," Autoimmunity Reviews, vol. 11, no. 12, pp. 883-889, 2012.
142. V. Ann, D. C. Kris, H. Daniel, L. Fu-Tong, D. B. Patrick, and S. Benôit, "Lack of galectin-3 alleviates trypanosomiasis-associated anemia of infammation," Immunobiology, vol. 215, no. 9-10, pp. 833-841, 2010.
143. B. Stijlemans, L. Leng, L. Brys et al., "MIF contributes to trypanosoma brucei associated immunopathogenicity development," PLoS Pathogens, vol. 10, no. 9, Article ID e1004414, 2014.
144. S. Magez, B. Stijlemans, T. Baral, and P. de Baetselier, "VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology," Microbes and Infection, vol. 4, no. 9, pp. 999-1006, 2002.
145. S. Magez, B. Stijlemans, M. Radwanska, E. Pays, M. A. J. Ferguson, and P. de Baetselier, "The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidyli-nositol anchor of the trypanosome variant-specifc surface gly-coprotein are distinct macrophage-activating factors," Journal of Immunology, vol. 160, no. 4, pp. 1949-1956, 1998.
146. B. Stijlemans, T. N. Baral, M. Guilliams et al., "A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology," The Journal of Immunology, vol. 179, no. 6, pp. 4003-4014, 2007.
147. B. Courtioux, C. Boda, G. Vatunga et al., "A link between chemokine levels and disease severity in human African try-panosomiasis," International Journal for Parasitology, vol. 36, no. 9, pp. 1057-1065, 2006.
148. A. Hainard, N. Tiberti, X. Robin et al., "A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients," PLoS Neglected Tropical Diseases, vol. 3, no. 6, article e459, 2009.
149. N. Tiberti, E. Matovu, A. Hainard et al., "New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients," Clinical and Translational Medicine, vol. 2, article 1, 2013.
150. K. Merschjohann and D. Steverding, "In vitro growth inhibition of bloodstream forms of Try panosomabrucei and Try panosoma congolense by iron chelators," Kinetoplastid Biology and Disease, vol. 5, article 3, 2006.
151. T. Breidbach, S. Scory, R. L. Krauth-Siegel, and D. Steverding, "Growth inhibition of bloodstream forms of Try panosom a brucei by the iron chelator deferoxamine," International Journal for Parasitology, vol. 32, no. 4, pp. 473-479, 2002.
152. M. Merk, S. Zierow, L. Leng et al., "The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 34, pp. E577-E585, 2011.
153. G. Langousis and K. L. Hill, "Motility and more: the fagellum of Try panosomabrucei," Nature Reviews Microbiology, vol. 12, no. 7, pp. 505-518, 2014.
154. B. Rotureau, C.-P. Ooi, D. Huet, S. Perrot, and P. Bastin, "Forward motility is essential for trypanosome infection in the tsetse fy," Cellular Microbiology, vol. 16, no. 3, pp. 425-433, 2014.
155. S. Alsford, M. C. Field, and D. Horn, "Receptor-mediated endo-cytosis for drug delivery in African trypanosomes: fulflling Paul Ehrlich's vision of chemotherapy," Trends in Parasitology, vol. 29, no. 5, pp. 207-212, 2013.
156. B. Stijlemans, G. Caljon, S. K. A. Natesan et al., "High afnity nanobodies against the Try panosomebrucei VSG are potent trypanolytic agents that block endocytosis," PLoS Pathogens, vol. 7, no. 6, Article ID e1002072, 2011.
157. S. Muyldermans, "Nanobodies: natural single-domain antibodies," Annual Review of Biochemistry, vol. 82, pp. 775-797, 2013.
158. T. N. Baral, S. Magez, B. Stijlemans et al., "Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor," Nature Medicine, vol. 12, no. 5, pp. 580-584, 2006.
159. A. Maier and D. Steverding, "Expression and purifcation of non-glycosylated Try panosomabrucei transferrin receptor in insect cells," Experimental Parasitology, vol. 120, no. 2, pp. 205-207, 2008.
160. M. A. J. Ferguson, J. S. Brimacombe, J. R. Brown et al., "The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness," Biochimica et Biophysica Acta, vol. 1455, no. 2-3, pp. 327-340, 1999.
161. Y. Yu, E. Gutierrez, Z. Kovacevic et al., "Iron chelators for the treatment of cancer," Current Medicinal Chemistry, vol. 19, no. 17, pp. 2689-2702, 2012.
162. A. H. Fairlamb, P. Blackburn, P. Ulrich, B. T. Chait, and A. Cerami, "Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids," Science, vol. 227, no. 4693, pp. 1485-1487, 1985.
163. A. Bocedi, K. F. Dawood, R. Fabrini et al., "Trypanothione efciently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites," The FASEB Journal, vol. 24, no. 4, pp. 1035-1042, 2010.
164. L. Flohé, "The trypanothione system and its implications in the therapy of trypanosomatid diseases," International Journal of Medical Microbiology, vol. 302, no. 4-5, pp. 216-220, 2012.
165. M. J. Nielsen and S. K. Moestrup, "Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging," Blood, vol. 114, no. 4, pp. 764-771, 2009.
166. L. Kǒrený, M. Oborník, J. Lukěs, and L. J. Knoll, "Make it, take it, or leave it: heme metabolism of parasites," PLoS Pathogens, vol. 9, no. 1, Article ID e1003088, 2013.